Endospan Ltd.
Clinical trials sponsored by Endospan Ltd., explained in plain language.
-
New stent system aims to tame dangerous aortic aneurysms
Disease control Recruiting nowThis study tracks 70 people receiving the NEXUS aortic arch stent graft, a device placed inside the aorta to treat aneurysms (bulging weak spots). Researchers will monitor safety, device failures, and survival for up to 5 years. The goal is to see how well the stent works in rout…
Sponsor: Endospan Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New stent graft could fix deadly aortic arch conditions
Disease control Recruiting nowThis study tests a new device called the NEXUS aortic arch stent graft system in 110 adults with serious conditions like aortic dissection or aneurysm affecting the aortic arch. The goal is to see if it is safe and effective at repairing the damaged area without major complicatio…
Phase: NA • Sponsor: Endospan Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC